- ►wanfang.gov.tw [DOC] RE Amori, J Lau, AG Pittas - Jama, 2007 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 248 - Related articles - BL Direct - All 8 versions
DJ Drucker, JB Buse, K Taylor, DM Kendall, M … - The Lancet, 2008 - Elsevier A 30-week, randomised, non-inferiority study compared a long-acting release formulation of
exenatide 2 mg administered once weekly to 10 μg exenatide administered twice a day, in 295
patients with type 2 diabetes (haemoglobin A 1c [HbA 1c ] 8·3% [SD 1·0], mean fasting ... Cited by 37 - Related articles - All 4 versions
A Barnett - Expert Opin. Pharmacother., 2007 - informahealthcare.com Exenatide is the first in a new class of compounds, which possess similar activity to the
naturally-occurring hormone glucagon-like peptide-1 (GLP-1). It mirrors many of the effects of
GLP-1, improving glycaemic control through a combination of mechanisms, which include ... Cited by 27 - Related articles - BL Direct - All 8 versions
S Madsbad, T Krarup, CF Deacon, JJ … - Current Opinion in Clinical …, 2008 - journals.lww.com Recent findings: The injectable glucagon-like peptide-1 receptor agonists exenatide significantly
improves glycaemic control, with average reductions in haemoglobin A1c of about 1.0%, fasting
plasma glucose of about 1.4 mmol/l, and causes a weight loss of approximately 2-3 kg ... Cited by 25 - Related articles - All 2 versions
- ►endojournals.org CW Chia, JM Egan - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Evidence Synthesis: Exenatide and liraglutide are injection based. Three-year follow-up data
on exenatide showed a sustained weight loss and glycosylated hemoglobin (HbA 1c ) reduction
of 1%. Nausea and vomiting are common. Results from phase 3 studies are pending on ... Cited by 24 - Related articles - All 5 versions
C Pan, W Yang, JP Barona, Y Wang, M Niggli, … - Diabetic …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 16 - Related articles - BL Direct - All 4 versions
AD Mazza, JE Morley - Journal of the American Medical Directors Association, 2007 - Elsevier Therapeutic focus in the long-term care population shifts toward medical management, ranging
from insulin to alternate interventions, such as metformin, sulfonylureas, thiazelionediones
(TZDs), α-glucosidase inhibitors, and, more recently, modulators of the incretin system. ... Cited by 15 - Related articles - All 15 versions
- ►endojournals.org M Salehi, BA Aulinger, DA D'Alessio - Endocrine Reviews, 2008 - Endocrine Soc THE LAST TWO DECADES have seen a major shift in the consensus on the pathogenesis of
type 2 diabetes mellitus (T2DM). Although it is clear that resistance of peripheral tissues to insulin
is an abnormality common to almost all patients with T2DM, the centrality of β-cell ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►endojournals.org SC Woods, DA D'Alessio - Journal of Clinical Endocrinology & …, 2008 - Endocrine Soc Evidence Synthesis: During meals, signals such as cholecystokinin arise primarily from the GI
tract to cause satiation and meal termination; signals secreted in proportion to body fat such as
insulin and leptin interact with satiation signals and provide effective regulation by ... Cited by 16 - Related articles - All 4 versions
M Combettes, C Kargar - Therapie, 2007 - edpsciences. org Abstract – Type 2 diabetes is an endocrine/metabolic disease characterized by
hyperglycemia. It is now well established that insulin resistance and pancreatic β-cell
dysfunction/failure are the two major components of the physiopathology of the disease. ... Cited by 10 - Related articles - All 3 versions
